CA1112164A - Compose de selenium therapeutique et utilisation - Google Patents

Compose de selenium therapeutique et utilisation

Info

Publication number
CA1112164A
CA1112164A CA307,652A CA307652A CA1112164A CA 1112164 A CA1112164 A CA 1112164A CA 307652 A CA307652 A CA 307652A CA 1112164 A CA1112164 A CA 1112164A
Authority
CA
Canada
Prior art keywords
selenium
therapeutic composition
therapeutic
composition
carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA307,652A
Other languages
English (en)
Inventor
Joseph R. Levitt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lundy Research Laboratories Inc
Original Assignee
Lundy Research Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundy Research Laboratories Inc filed Critical Lundy Research Laboratories Inc
Application granted granted Critical
Publication of CA1112164A publication Critical patent/CA1112164A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21001—Chymotrypsin (3.4.21.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22002—Papain (3.4.22.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22033—Fruit bromelain (3.4.22.33), i.e. juice bromelain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA307,652A 1977-08-02 1978-07-18 Compose de selenium therapeutique et utilisation Expired CA1112164A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82115677A 1977-08-02 1977-08-02
US821,156 1977-08-02

Publications (1)

Publication Number Publication Date
CA1112164A true CA1112164A (fr) 1981-11-10

Family

ID=25232663

Family Applications (1)

Application Number Title Priority Date Filing Date
CA307,652A Expired CA1112164A (fr) 1977-08-02 1978-07-18 Compose de selenium therapeutique et utilisation

Country Status (4)

Country Link
EP (1) EP0000670A1 (fr)
JP (1) JPS5459309A (fr)
CA (1) CA1112164A (fr)
IT (1) IT1107965B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027075A1 (de) * 1980-07-17 1982-02-18 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
SE8105887L (sv) * 1981-10-06 1983-04-07 Erland Johansson Blandning for human tillforsel av selen som sparemne
ATE29217T1 (de) * 1982-03-30 1987-09-15 Hoechst Uk Ltd Anthelmintika.
IL69353A0 (en) * 1983-07-27 1984-01-31 Berman Daniel Skin ointment comprising herbal extracts
AT412448B (de) * 2001-02-13 2005-03-25 Vis Vitalis Lizenz & Handels Verwendung von selenhältigen präparaten
AT412703B (de) 2001-12-04 2005-06-27 Vis Vitalis Lizenz & Handels Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung
DE102004063638A1 (de) * 2004-12-31 2006-07-13 Biosyn Arzneimittel Gmbh Selen-haltige Medikamente zur Prophylaxe oder Therapie von endothelialen Gefäßerkrankungen
AT511159A1 (de) 2011-02-16 2012-09-15 Selo Medical Gmbh Pharmazeutische zusammensetzungen enthaltend selenit- oder selenathältige verbindungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928578A (en) * 1967-04-28 1975-12-23 Chromalloy Pharmaceutical Inc Composition for control of white muscle disease
FR2263780A1 (en) * 1973-05-03 1975-10-10 Philagro Sa Selenium additives for poultry feed - containing selenites or selenates for reducing stress-induced conditions such as pecking or cannibalism
GB1444024A (en) * 1973-07-20 1976-07-28 Passwaterr A Food and feed supplents

Also Published As

Publication number Publication date
EP0000670A1 (fr) 1979-02-07
IT1107965B (it) 1985-12-02
IT7850509A0 (it) 1978-07-27
JPS5459309A (en) 1979-05-12

Similar Documents

Publication Publication Date Title
US4512977A (en) Therapeutic selenium compositions and the use thereof
US5538740A (en) Therapeutic and cosmetic compositions for treatment of skin
US4588744A (en) Method of forming an aqueous solution of 3-3-Bis(p-hydroxyphenyl)-phthalide
US6261574B1 (en) Cream formulation for topical application
US4585656A (en) Treatment of herpes
BG64522B1 (bg) Средство за лечение на вирусни инфекциозни заболявания
JPS60100517A (ja) 放射線潰瘍治療剤および方法
JP2003502071A (ja) 魚類セリンプロティナーゼ及びそれらの薬品及び化粧品への利用
WO1994009798A1 (fr) Melanges ou complexes contenant du calcium et du sulfate
CN108853312A (zh) 聚桂醇外用凝胶及其制备方法
AU5550094A (en) Compositions of oak bark extract, related synthetic compositions, and method of using same
US4961927A (en) Clear solution containing lysozyme hydrochloride and dipotassium glycyrrhizinate
EP0531495B1 (fr) Compositions therapeutiques et cosmetiques pour le traitement de la peau
EP0988040B1 (fr) Utilisation de glucosamine et de derives de glucosamine pour le soulagement rapide de prurit ou de douleurs localisees
US4708873A (en) Method of chemically debriding uncerated necrotic tissue
ES2253772T3 (es) Utilizacion de sales de zinc de acidos linoleicos conjugados para el tratamiento de afecciones cutaneas.
CA1112164A (fr) Compose de selenium therapeutique et utilisation
US4340590A (en) Method for reducing or inhibiting ecchymosis in skin tissues with inorganic selenium compositions
EP0484112A2 (fr) Utilisation du lithium dans le traitement ou la prophylaxie du Molluscum contagiosum
GB2263234A (en) Malotilate for accelerating wound healing
US3026247A (en) Pharmaceutical preparation
EP0073758B1 (fr) Traitement des infections virales inflammatoires, de l'acne, des dermatites et de l'arthrite
US5576005A (en) Effectiveness of wart removal by compositions including propolis
KR20100111061A (ko) 상처 치료용 조성물
JPH0259519A (ja) 皮膚炎症治療剤

Legal Events

Date Code Title Description
MKEX Expiry